Product Information
PRALUENT 75 MG/ML PEN is a brand product labeled by Regeneron Pharmaceuticals, Inc., priced at $257.7315 per ML under NDC 61755002002. Its NADAC has been published 266 times since Jul 21, 2021.
Strength
75 mg/mL
Manufacturer
Regeneron Pharmaceuticals, Inc.NDC
61755002002
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
ALIROCUMABApproval Type
Biologic (BLA)
FDA Application
BLA125559On Market Since
12/1/2020
Pharmacological Classes
Price Statistics
The NADAC for PRALUENT 75 MG/ML PEN has been published 266 times since Jul 21, 2021, and over the history we have for it it has risen 18.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $257.7315 per ML |
|---|---|
| All-time high | $258.0650 (May 13, 2026) |
| All-time low | $217.2101 (Jul 21, 2021) |
| 52-week high | $258.0650 |
| 52-week low | $250.5355 |
| Median price | $243.8823 |
| Average price | $240.6009 |
| Largest weekly change | +3.0% (Jul 27, 2022) |
| Weeks tracked | 266 |
| Tracking since | Jul 21, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the alirocumab market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PRALUENT 75 MG/ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for PRALUENT 75 MG/ML PEN, manufactured by Regeneron Pharmaceuticals, Inc., is $257.7315 per ML (NDC 61755002002), effective Aug 19, 2026.
How has the price of PRALUENT 75 MG/ML PEN changed over time?
Over the history we have for it, the NADAC for PRALUENT 75 MG/ML PEN has risen 18.7%. It has been tracked across 266 weekly CMS publications since Jul 21, 2021.
What are the highest and lowest recorded NADAC prices for PRALUENT 75 MG/ML PEN?
Since Jul 21, 2021, the NADAC for PRALUENT 75 MG/ML PEN has ranged from a low of $217.2101 (Jul 21, 2021) to a high of $258.0650 (May 13, 2026), with a median of $243.8823 per ML.
Are there cheaper alternatives to PRALUENT 75 MG/ML PEN?
No other NADAC-published product currently shares the active ingredient and strength of PRALUENT 75 MG/ML PEN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PRALUENT 75 MG/ML PEN?
PRALUENT 75 MG/ML PEN (NDC 61755002002) is labeled by Regeneron Pharmaceuticals, Inc., and CMS classifies it as a brand product.